title: Comparison of protective effect of protein and DNA vaccines hsp90 in murine model of systemic candidiasis.
abstract: Preventive vaccination by a hsp90-expressing DNA vaccine and recombinant hsp90 protein vaccine, both derived from the Candida albicans hsp90 using BALB-c mouse model of systemic candidiasis, was performed. Hsp90 mRNA was cloned from a clinical isolate of C. albicans, converted to cDNA and cloned into vaccination plasmid pVAX1. Two methods of DNA application were tested: intramuscular (i.m.) and intradermal (i.d.) injection. Recombinant protein was applied by i.d. injection with Freund's adjuvant; the control groups received PBS or Freund's adjuvant only. Mice were vaccinated and after 19 d re-vaccinated. After 3 weeks, the mice were challenged with the live C. albicans in a dose of 5 x 10(6) CFU per mouse. After the challenge, the mice vaccinated i.d. with DNA vaccine survived for 39 and 64% longer compared to those receiving Freund's adjuvant and/or PBS, respectively. The i.m. application of the DNA vaccine did not provide any significant protectivity. The serum level of anti-candida-hsp90 serum IgG antibodies correlated with the survival rate in both i.d. protein and DNA vaccination approaches. We stressed the importance of specific humoral immunity in the mouse model of systemic candidiasis.
authors.affiliation: Department of Immunology, Faculty of Medicine, Palacký University, Olomouc, Czechia. mr7995@uab.edu
authors.forename: M
authors.initials: M
authors.lastname: Raska
authors.forename: J
authors.initials: J
authors.lastname: Beláková
authors.forename: N K
authors.initials: NK
authors.lastname: Wudattu
authors.forename: L
authors.initials: L
authors.lastname: Kafková
authors.forename: K
authors.initials: K
authors.lastname: Růzicková
authors.forename: M
authors.initials: M
authors.lastname: Sebestová
authors.forename: Z
authors.initials: Z
authors.lastname: Kolár
authors.forename: E
authors.initials: E
authors.lastname: Weigl
mesh_terms: D000818:Animals; D000908:Antibodies, Fungal / Q000097:blood; D002176:Candida albicans / Q000276:immunology*; D002177:Candidiasis / Q000517:prevention & control*; D004195:Disease Models, Animal; D005620:Freund's Adjuvant; D005657:Fungal Vaccines / Q000008:administration & dosage / Q000276:immunology*; D018841:HSP90 Heat-Shock Proteins / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology*; D007074:Immunoglobulin G / Q000097:blood; D007271:Injections, Intradermal; D007273:Injections, Intramuscular; D051379:Mice; D008807:Mice, Inbred BALB C; D016019:Survival Analysis; D019444:Vaccines, DNA / Q000008:administration & dosage / Q000276:immunology*; D022223:Vaccines, Subunit / Q000008:administration & dosage / Q000276:immunology*; D014614:Vaccines, Synthetic / Q000008:administration & dosage / Q000276:immunology
chemical_list: D000908:Antibodies, Fungal; D005657:Fungal Vaccines; D018841:HSP90 Heat-Shock Proteins; D007074:Immunoglobulin G; D019444:Vaccines, DNA; D022223:Vaccines, Subunit; D014614:Vaccines, Synthetic; D005620:Freund's Adjuvant